Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #103
- Final score
- 65.54
- Years on list
- 6
↗ Climbed 162 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 162 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 91 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 35 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | MTD | MRK | TMO |
|---|---|---|---|
| Climate Change | 83.4 | 68.4 | 80.9 |
| Employee Relations | 44.1 | 59.5 | 49.6 |
| Environment | 69.2 | 69.2 | 74.0 |
| Stakeholders & Society | 77.4 | 68.4 | 61.7 |
| Human Rights | 54.7 | 72.8 | 58.1 |
| Governance | 61.5 | 47.8 | 55.9 |
| Performance Rating | 57.8 | 73.9 | 62.8 |